home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Arysta LifeScience North America and FMC Corporation sign licensing agreement for professional turf and ornamental products


Cary, North Carolina, USA
August 14, 2014

Arysta LifeScience North America, LLC and FMC Corporation have announced the signing of an exclusive licensing agreement in the United States and Canada, in which FMC will develop, market and sell two key turf and ornamental (T&O) products, DISARM® Fungicide (fluoxastrobin) and XONERATE® Herbicide (amicarbazone), from Arysta LifeScience. The agreement is effective as of August 12, 2014.

The DISARM (fluoxastrobin) Fungicide line includes four formulations, each specifically tailored to regional climate, disease history and turf-grass variety. DISARM can be used alone or in chlorothalonil-based or DMI-based premixes. XONERATE is a post-emergent herbicide, representing new turf grass chemistry for the control of Poa annua.

“We have built substantial markets for these important T&O products over the last few years,” explained Amy Yoder, business unit head of Arysta LifeScience North America. “Licensing the sales, marketing and distribution of DISARM and XONERATE will allow these T&O products to grow at a faster rate and allow us to focus on our growing portfolio of agricultural crop protection products.”

“This exclusive agreement unites two complementary product lines, expanding FMC Professional Solutions turf and ornamental portfolio and further demonstrating our commitment to grow beyond agriculture to invest in the professional services markets,” said Mark Douglas, president, FMC Agricultural Solutions. “Additionally, this relationship opens exciting new development opportunities for the FMC Professional Solutions turf and ornamental business.”

The companies did not disclose the financial terms of the agreement.



More news from:
    . Arysta LifeScience Corporation
    . FMC Corporation


Website: http://www.arystalifescience.com

Published: August 14, 2014

The news item on this page is copyright by the organization where it originated
Fair use notice

 

 

 

 

 

 

 

 

 

 

 


Copyright @ 1992-2024 SeedQuest - All rights reserved